Agalactosyl IgG and Antibody Specificity in Rheumatoid Arthritis, Tuberculosis, Systemic Lupus Erythematosus and Myasthenia Gravis

References

• Parekh R. B., Dwek R. A., Sutton B. J., Fernandes D. L., Leung A., Stanworth D. R., et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985; 316: 452–457
   PubMed Web of Science ®Google Scholar
• Rademacher T., Parekh R. B., Dwek R. A., Isenberg D., Rook G. A.W., Axford J. S., et al. The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis. Springer Semin. Immunopathol. 1988; 10: 231–249
   PubMedGoogle Scholar
• Rademacher T. W., Williams P., Dwek R. A. Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc. Natl. Acad. Sci. USA. 1994; 91: 6123–6127
   PubMed Web of Science ®Google Scholar
• Tsuchiya N., Endo T., Matsuta K., Yoshinoya S., Aikawa T., Kosuge E., et al. Effect of galactose depletion from oligosaccharide chains on immunological activities of human IgG. J. Rheumatol. 1989; 16: 289–290
   Google Scholar
• Dube R., Rook G. A., Steele J., Brealey R., Dwek R., Rademacher T., et al. Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein. Gut. 1990; 31: 431–434
   PubMedGoogle Scholar
• Rook G. A.W., Onyebujoh P., Wilkins E., Ho Minh Ly Al, Attiyah R., Bahr G M, et al. A longitudinal study of % agalactosyl IgG in tuberculosis patients receiving chemotherapy, with or without immunotherapy. Immunol. 1994; 81: 149–154
   PubMedGoogle Scholar
• Filley E., Andreoli A., Steele J., Waters M., Wagner D., Nelson D., et al. A transient rise in agalactosyl IgG correlating with free IL-2 receptors during episodes of erythema nodosum leprosum. Clin. Exp. Immunol. 1989; 76: 343–347
   PubMed Web of Science ®Google Scholar
• Parekh R. B., Isenberg D., Rook G. A.W., Roitt I., Dwek R., Rademacher T. A comparative analysis of disease associated changes in galactosylation of serum IgG. J. Autoimmun. 1989; 2: 101–114
   PubMed Web of Science ®Google Scholar
• Bahr G. M., Yousof A. M., Majeed H. A.M., Behbehani K., Lubani M., Parekh R. B., et al. Agalactosyl IgG, antibodies to heat shock proteins, and acute rheumatic fever. Ann. Rheum. Dis. 1990; 49: 383–386
   PubMedGoogle Scholar
• Young A., Sumar N., Bodman K., Goyal S., Sinclair H., Roitt I., et al. Agalactosyl IgG: an aid to differential diagnosis in early synovitis. Arthritis. Rheum. 1991; 34: 1425–1429
   PubMed Web of Science ®Google Scholar
• van Zeben D., Rook G. A.W., Hazes J. M.W., Zwinderman A. H., Zhang Y., Ghelani S., et al. Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study. Brit. J. Rheumatol. 1994; 33: 36–43
   PubMedGoogle Scholar
• Rook G. A.W., Steele J., Brealey R., Whyte A., Isenberg D., Sumar N., et al. Changes in IgG glycoform levels are associated with remssion of arthritis during pregnancy. J. Autoimm. 1991; 4: 779–794
   PubMed Web of Science ®Google Scholar
• Parekh R. B., Isenberg D. A., Roitt I. M., Dwek R. A., Ansell B. M., Rademacher T. W. Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. Lancet 1988; i: 966–969
   Google Scholar
• Pilkington C., Lefvert A.-K., Rook G. A.W. Neonatal myasthenia gravis and the role of agalactosyl IgG. Autoimmunity 1995, In press
   Google Scholar
• Sutton B. J., Phillips D. C. The three dimensional structure of the carbohydrate within the Fc fragment of immunoglobulin G. Biochem. Soc. Trans. 1983; 11: 130–132
   Web of Science ®Google Scholar
• Parekh R., Isenberg D., Roitt I., Dwek R., Rademacher T. Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J. Exp. Med. 1988; 167: 1731–1736
   PubMed Web of Science ®Google Scholar
• Rook G. A.W., Steele J., Rademacher T. A monoclonal antibody raised by immunising mice with group A streptococci binds to agalactosyl IgG from rheumatoid arthritis. Ann. Rheum. Dis. 1988; 47: 247–250
   PubMed Web of Science ®Google Scholar
• McCulloch J., Zang Y. W., Dawson M., Harkiss G. D., Peternans H., Vogt H. R., et al. Glycosylation of IgG during potentially arthritogenic lentiviral infections. Rheumatol. Int. 1994; 14: 243–248
   Google Scholar
• Pilkington C., Wang Y., Rook G. A.W. The disease distribution and pathogenetic significance of agalactosyl IgG. Abnormalities of IgG glycosylation in immunological diseases, D. A. Isenberg, T. W. Rademacher. John Wylie & Sons Ltd, Chichester 1995
   Google Scholar
• Rook G. A.W., Standard J. L. Adjuvants, endocrines and conserved epitopes; factors to consider when designing “Therapeutic Vaccines”. Int. J. Immunopharmac. 1995; 17: 91–102
   PubMedGoogle Scholar
• Rook G. A.W., Thompson S., Buckley M., Elson C., Brealey R., Lambert C., et al. The role of oil and agalactosyl IgG in the induction of arthiritis in rodent models. Eur. J. Immunol. 1991; 21: 1027–1032
   PubMed Web of Science ®Google Scholar
• Hitsumoto Y., Thompson S. J., Zhang Y., Rook G. A.W., Elson C. J. Relationship between interleukin 6, agalactosyl IgG and pristane-induced arthritis. Autoimmunity 1992; 11: 247–254
   PubMed Web of Science ®Google Scholar
• Field M., Chu C., Feldman M., Maini R. Interleukin-6 in the synovial membrane in rheumatoid arthritis. Rheum. Int. 1991; 11: 45–57
   PubMed Web of Science ®Google Scholar
• Nakao H., Nishikawa A., Nishiura T., Kanayama Y., Tarui S., Taniguchi N. Hypogalactosylation of immunoglobulin G sugar chains and elevated serum interleukin 6 in Castleman's disease. Clin. Chim. Acta 1991; 197: 221–228
   PubMed Web of Science ®Google Scholar
• Schurmann G., Betzler M. and Post S. Soluble IL-2 receptor, IL-6, and interleukin 1β in patients with Crohn's disease and ulcerative colitis: pre-operative and post-operative changes in serum concentrations. Digestion 1992; 51: 51–59
   PubMedGoogle Scholar
• Houssiau F. A., Devogelaer J. P., van Damme J., Nagant de Deuxchaisnes C., van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 1988; 31: 784–789
   PubMed Web of Science ®Google Scholar